Related Experiment Videos

The COOH terminus of p18INK4C distinguishes function from p16INK4A

J Gump1, S Turner, J Koh

  • 1Department of Molecular Physiology, University of Vermont, Burlington, VT 05405, USA.

Cancer Research
|May 19, 2001
PubMed

Insights

The INK4 protein family regulates cell cycle progression. Unlike p16(INK4a), p18(INK4c) shows distinct tumor mutation profiles, suggesting novel regulatory mechanisms.

Area of Science:

  • Molecular Biology
  • Cell Cycle Regulation
  • Oncology

Background:

  • The INK4 protein family, including p16(INK4a) and p18(INK4c), inhibits cyclin-dependent kinases (cdks) 4 and 6.
  • INK4 proteins block cell cycle progression from G(1) to S phase.
  • p16(INK4a) is frequently inactivated in human tumors, whereas p18(INK4c) alterations are rare.

Purpose of the Study:

  • To investigate the functional differences between p16(INK4a) and p18(INK4c).
  • To explore potential novel regulatory mechanisms of p18(INK4c).
  • To understand the distinct mutational profiles of p16(INK4a) and p18(INK4c) in tumors.

Main Methods:

  • Overexpression of p18(INK4c) in a T-cell acute lymphocytic leukemia cell line (CEM).
  • Assessment of G(1) arrest in response to p18(INK4c) overexpression.
  • Construction and functional analysis of a p16(INK4a)/p18(INK4c) chimera.

Main Results:

  • p18(INK4c) overexpression did not arrest CEM cells, which are sensitive to p16(INK4a).
  • A chimera with the p16(INK4a) kinase-binding region and p18(INK4c) COOH terminus retained INK4 biochemical activity.
  • The chimera failed to arrest CEM cells, indicating regulation via the COOH terminus.

Conclusions:

  • A novel regulatory mechanism for p18(INK4c) likely involves its COOH terminus.
  • Functional differences between p16(INK4a) and p18(INK4c) may explain their distinct tumor mutation patterns.
  • Further research into p18(INK4c) regulation is warranted.

Related Concept Videos